Literature DB >> 1731022

Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes.

A Bettinelli1, M G Bianchetti, E Girardin, A Caringella, M Cecconi, A C Appiani, L Pavanello, R Gastaldi, C Isimbaldi, G Lama.   

Abstract

Clinical or biochemical findings were reevaluated in 34 pediatric patients with primary renal tubular hypokalemic metabolic alkalosis. The patients were subdivided into two groups. Bartter syndrome (primary renal tubular hypokalemic metabolic alkalosis with normocalciuria or hypercalciuria) was diagnosed in 18 patients with molar urinary calcium/creatinine ratios greater than 0.20, and Gitelman syndrome (primary renal tubular hypokalemic metabolic alkalosis with magnesium deficiency and hypocalciuria) was diagnosed in 16 patients with molar urinary calcium/creatinine ratios less than or equal to 0.20 and plasma magnesium levels less than 0.75 mmol/L. Some clinically important differences between the groups were observed. Patients with Bartter syndrome were often born after pregnancies complicated by polyhydramnios (8/18) or premature delivery (7/18) and had short stature (11/18) or polyuria, polydipsia, and a tendency to dehydration (16/18) during infancy (12/18) or before school age (18/18). Patients with Gitelman syndrome had tetanic episodes (12/16) or short stature (3/16) at school age (14/16). We conclude that the Bartter and Gitelman syndromes represent two distinct variants of primary renal tubular hypokalemic metabolic alkalosis and are easily distinguished on the basis of urinary calcium levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731022     DOI: 10.1016/s0022-3476(05)80594-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  55 in total

Review 1.  The pathophysiological and molecular basis of Bartter's and Gitelman's syndromes.

Authors:  S Bhandari
Journal:  Postgrad Med J       Date:  1999-07       Impact factor: 2.401

2.  Gitelman's syndrome.

Authors:  H M Ismail; T Jagadeesh; R V Bhat
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

Review 3.  Hypomagnesemia and hypermagnesemia.

Authors:  Joel Michels Topf; Patrick T Murray
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

4.  Magnesium disorders: clinical experience and review of the literature.

Authors:  Maria Laura De Feo
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

5.  Potassium Homeostasis, Oxidative Stress, and Human Disease.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  Int J Clin Exp Physiol       Date:  2017

Review 6.  Salt handling and hypertension.

Authors:  Kevin M O'Shaughnessy; Fiona E Karet
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

7.  Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman's syndrome.

Authors:  Noriko Aoi; Tomohiro Nakayama; Yoshiko Tahira; Akira Haketa; Minako Yabuki; Tadataka Sekiyama; Chie Nakane; Hiroaki Mano; Hideomi Kawachi; Naoyuki Sato; Masayoshi Soma; Kouichi Matsumoto
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

8.  A rare case of Gitelman's syndrome presenting with hypocalcemia and osteopenia.

Authors:  A Nakamura; C Shimizu; S Nagai; S Taniguchi; M Umetsu; T Atsumi; N Yoshioka; Y Ono; T Tajima; M Kubo; T Koike
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 9.  Longitudinal growth in chronic hypokalemic disorders.

Authors:  Helena Gil-Peña; Natalia Mejia; Oscar Alvarez-Garcia; Vanessa Loredo; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

10.  Aldosterone and testosterone producing adrenal adenoma in childhood.

Authors:  K Schmitt; H Frisch; N Neuhold; G Burda; E Schober
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.